Nektar Therapeutics (FRA:ITH0)
€ 53.62 -2.52 (-4.49%) Market Cap: 1.89 Bil Enterprise Value: 1.47 Bil PE Ratio: 0 PB Ratio: 3.25 GF Score: 47/100

Nektar Therapeutics Annual Shareholders Meeting Transcript

Jun 04, 2026 / 09:00PM GMT
Release Date Price: €50.18 (+0.76%)
Elizabeth Zhang
Nektar Therapeutics - Vice President, Legal and Corporate Counsel

Hello. I would like to welcome everyone to the 2026 Annual Meeting of Stockholders of Nektar Therapeutics. My name is Elizabeth Zhang, Vice President, Legal and Corporate Counsel at Nektar. It is my pleasure to host the 2026 Annual Meeting. I will serve as Secretary of the meeting. I am joined today with Howard Robin, our President and CEO; and members of our Board of Directors and the Nektar executive team. Representatives of Ernst & Young, our independent auditors, are also with us.

We will now turn to the formal business portion of Agenda. When that is complete, I will turn the meeting over to Howard Robin to provide an overview of business highlights from the past year, and then we will open the floor for stockholder questions.

The 2026 Annual Meeting of the Stockholders of Nektar Therapeutics will now officially come to order.

I have at this meeting a complete list of the stockholders of record of the company's common stock on April 6, 2026, the record date for this meeting. I also have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot